RecruitingNot ApplicableNCT06456554
Acellular Dermal Matrix Investigation in Breast Reconstruction
Sponsor
RTI Surgical
Enrollment
467 participants
Start Date
Nov 22, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Prospective, multi-center, dual-arm non-randomized clinical study in females undergoing a two-stage breast reconstruction using a pre-pectoral technique.
Eligibility
Sex: FEMALEMin Age: 22 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Acellular Dermal Matrix (Cortiva Tissue Matrix) for people with breast reconstruction. The study is currently recruiting participants at 13 locations. People eligible for this study include women aged 22 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAcellular Dermal Matrix (Cortiva Tissue Matrix)
non-crosslinked dermis
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06456554
Related Trials
EndoBreast Study - Assessment of Feasibility, Functional Outcomes, and Sensitivity of the Areola-Nipple Complex in Endoscopic Mastectomy
NCT077184251 location
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
NCT0657519222 locations
Access My Breast Cancer Care App
NCT076966372 locations
Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon
NCT072647901 location
A Post-market Prospective Clinical Study of Eurosilicone Luna Mammary Implants
NCT076795942 locations